Latest / Stock Movers / Home Depot, AMD Rises; Novo Sinks on Obesity Flop
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at the stocks on the move today.
- 0:18Speaker 3: I'm Tim Steneviek along with Carol Master. We are joined
- 0:21Speaker 3: by Bloomberg Television Markets correspondent Normal Linda. Did you find
- 0:24Speaker 3: any stocks that we're moving lower?
- 0:25Speaker 4: Yeah, but I'll save that for a little later. We're
- 0:27Speaker 4: going to start with one that's in the green. I'm
- 0:29Speaker 4: looking at shares of Home Depot. This is the company
- 0:32Speaker 4: that reported We did see pretty much a beat across
- 0:34Speaker 4: the border, especially as we look at the key metrics
- 0:36Speaker 4: for sales. But there's still a lot of concern out
- 0:39Speaker 4: in the market. People are thinking about the macroeconomic environment
- 0:42Speaker 4: and how it still continues to weigh on the real
- 0:45Speaker 4: estate industry and any sort of home improvement related company.
- 0:49Speaker 4: So you do see shares of Home Depot on the
- 0:51Speaker 4: rise or up about two point three percent right now
- 0:53Speaker 4: as we speak. If you take a look at the
- 0:54Speaker 4: year to day basis, they're up about almost twelve percent
- 0:57Speaker 4: so far this year. But as I was speaking to
- 0:59Speaker 4: so and is we're really seeing a lot of people
- 1:01Speaker 4: talking about on Wall Street. It's just still that concern
- 1:04Speaker 4: as to whether or not we're actually able to see
- 1:06Speaker 4: this company being able to really weather the storm that
- 1:09Speaker 4: is the macro and some saying that we've been seeing
- 1:12Speaker 4: this for years after year after year. Maybe how many
- 1:16Speaker 4: people need to get a little bit more creative with
- 1:18Speaker 4: how they're actually able to grapple with this situation that's
- 1:20Speaker 4: not their.
- 1:21Speaker 5: Fault, yeah, I mean tied to the consumer, right, like
- 1:27Speaker 5: projects and contractors, right, that's a big part of their business, right,
- 1:30Speaker 5: So uh yeah, we'll.
- 1:32Speaker 4: Have to keep an eye. I mean earlier hit it's
- 1:34Speaker 4: highest since November, and we do have its peer Lowe's
- 1:37Speaker 4: reporting tomorrow.
- 1:38Speaker 1: Yeah, all right, check of retail eighty five dollars stock. Yeah,
- 1:42Speaker 1: it's still pricey. I don't know, I don't know what
- 1:47Speaker 1: I would not say that, but it's you said maybe
- 1:51Speaker 1: maybe say maybe, I don't know that's operative word there.
- 1:57Speaker 5: All right, Let's go to something we were talking about
- 1:59Speaker 5: a lot on Monday, right, the battle between Novo and Elilu.
- 2:03Speaker 4: Yeah, I mean, Tim, you want some decliners want take
- 2:06Speaker 4: a look at Novo Nordis take our Envo tick r
- 2:09Speaker 4: ll Y both declining. We know that this story continues
- 2:12Speaker 4: to evolve, as we've been seeing the most of them
- 2:14Speaker 4: kind of going head to head. But the latest news
- 2:17Speaker 4: is that Novo Nordis plans to slash the US prices
- 2:20Speaker 4: for its medicines will Gov and Ozembic next year. We
- 2:23Speaker 4: know that this is a company that's really been struggling
- 2:25Speaker 4: when we think about itself keeping up as a major
- 2:28Speaker 4: competitor in this space as we think about the obesity
- 2:30Speaker 4: weight loss drug industry more broadly. They're saying that the
- 2:34Speaker 4: lower prices could reduce out of pocket costs for some
- 2:37Speaker 4: customers that have insurance that requires them to cover a
- 2:40Speaker 4: larger portion of their drug costs. But we'll have to
- 2:43Speaker 4: see how this trickles out. But as for now on
- 2:45Speaker 4: Wall Street, it seems as though people are still a
- 2:47Speaker 4: bit skeptical, skeptical about the company as a whole, and
- 2:50Speaker 4: you're seeing its peer Eliley also falling after this news.
- 2:54Speaker 5: Maybe they're just cranky over yesterday's news, right, they had
- 2:57Speaker 5: some disappointment and maybe yeah, to go up against an
- 3:03Speaker 5: Eli Lilly product, and maybe they're just like, we'll take that,
- 3:07Speaker 5: We'll just devices. I'm just guessing Vice is notculating not
- 3:11Speaker 5: good for companies, but good for consumers. Yeah, hopefully right, Yeah,
- 3:15Speaker 5: all right, I love this. We talked about this, We
- 3:18Speaker 5: all are talking about this a lot. Advanced micro devices.
- 3:21Speaker 4: Yes, I mean, we can't keep our eyes off of
- 3:23Speaker 4: tech at this point, as we've really been digging into
- 3:25Speaker 4: some of these companies. Shares of AMD today up about
- 3:28Speaker 4: nine percent right now in the trade. This is, of course,
- 3:31Speaker 4: after Meta said that it would buy the company's chips
- 3:34Speaker 4: and computers designed to run AI models. We see AMD
- 3:38Speaker 4: as a second best performing stock in the S and
- 3:40Speaker 4: P five hundred today, So clearly Wall Street is taking
- 3:43Speaker 4: a liking to this. Take a look at shares of AMD,
- 3:46Speaker 4: though year to date not too much action. They're what
- 3:48Speaker 4: just below flat on the year, down about one tenth
- 3:50Speaker 4: of a percent year to date here in twenty twenty six.
- 3:53Speaker 4: But this deal in particular is expected to begin in
- 3:55Speaker 4: the second half of twenty twenty six, and they're saying
- 3:58Speaker 4: that it'll be worth double digit billions of dollars per gigawatt,
- 4:02Speaker 4: So massive action that we're seeing here, and certainly you're
- 4:05Speaker 4: seeing Wall Street taking a liking.
- 4:07Speaker 5: An AMD was a star last year. Is that like
- 4:10Speaker 5: seventy seven, seventy eight percent.
- 4:12Speaker 3: So yeah's I'm slicking at the year today, Yeah, glad.
- 4:15Speaker 3: But at two hundred and fifteen dollars a share right
- 4:18Speaker 3: now today, it's surging. And remember, as Ed reminded us.
- 4:21Speaker 5: Six ninety nine, what was this six six it has.
- 4:24Speaker 1: To do, yeah, for one of the warrants, for one
- 4:26Speaker 1: of the warrants for Meta.
- 4:27Speaker 3: This is it's the structure of the deal is a
- 4:29Speaker 3: little different than other you know, quote unquote deals that
- 4:32Speaker 3: we've seen between the hyperscalers.
- 4:34Speaker 1: Yeah.
- 4:35Speaker 3: Yeah, and Met as a different company too, because it's
- 4:38Speaker 3: not it's doesn't sell capacity like you know, these other
- 4:42Speaker 3: providers like an AWS or Microsoft. So yeah, yeah, it's
- 4:45Speaker 3: still still questions about the you know, quote unquote circular funding.
- 4:48Speaker 5: But if it exercises all those if Meta exercises all
- 4:51Speaker 5: those warrants, right, they could become a very significant shareholder
- 4:54Speaker 5: in AMD.
- 4:56Speaker 2: This stock Mover's report from Bloomberg Radio. Back with us
- 5:00Speaker 2: throughout the day for the latest roundup of companies making
- 5:03Speaker 2: news on Wall Street and for the latest market moving headlines.
- 5:07Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 5:11Speaker 2: dot com, and on Applecarplay. And Android Auto with the
- 5:14Speaker 2: Bloomberg Business App.